Salem Investment Counselors Inc. Makes New $15.90 Million Investment in Astera Labs, Inc. $ALAB

Key Points

• Salem Investment Counselors Inc. has acquired a new stake in Astera Labs, purchasing 175,844 shares valued at approximately $15.90 million, representing 0.11% of the company's stock.
• Astera Labs has seen a significant uptick in institutional interest, with multiple investors like Fred Alger Management LLC and UBS AM dramatically increasing their positions in recent quarters.
• Analysts have largely favorable views on Astera Labs, with numerous upgrades and price target increases, leading to a consensus rating of "Moderate Buy" and an average price target of $142.00.

Salem Investment Counselors Inc. purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 175,844 shares of the company's stock, valued at approximately $15,900,000. Salem Investment Counselors Inc. owned 0.11% of Astera Labs as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Sound Income Strategies LLC lifted its stake in Astera Labs by 34.7% during the first quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after purchasing an additional 204 shares during the period. GAMMA Investing LLC lifted its stake in Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after purchasing an additional 284 shares during the period. Harbour Investments Inc. lifted its stake in Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock worth $47,000 after purchasing an additional 619 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new stake in Astera Labs during the first quarter worth about $48,000. Finally, Hazlett Burt & Watson Inc. grew its stake in Astera Labs by 1,670.0% during the first quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company's stock worth $53,000 after buying an additional 835 shares during the last quarter. Institutional investors own 60.47% of the company's stock.

Astera Labs Price Performance

Shares of NASDAQ ALAB traded up $1.79 during midday trading on Monday, hitting $231.29. The stock had a trading volume of 3,248,667 shares, compared to its average volume of 4,959,556. The firm has a market cap of $38.44 billion, a P/E ratio of 413.02, a price-to-earnings-growth ratio of 5.82 and a beta of 1.48. Astera Labs, Inc. has a fifty-two week low of $42.80 and a fifty-two week high of $237.82. The company's 50-day simple moving average is $155.12 and its 200 day simple moving average is $104.02.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm's quarterly revenue was up 149.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Activity

In other Astera Labs news, CEO Jitendra Mohan sold 91,441 shares of the business's stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the sale, the chief executive officer directly owned 2,170,877 shares of the company's stock, valued at approximately $398,377,638.27. The trade was a 4.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total value of $31,708,410.00. Following the sale, the director directly owned 385,863 shares of the company's stock, valued at $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,832,489 shares of company stock worth $264,172,396. Corporate insiders own 12.50% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ALAB. Wall Street Zen upgraded shares of Astera Labs from a "hold" rating to a "buy" rating in a research note on Saturday, August 16th. Stifel Nicolaus set a $145.00 target price on shares of Astera Labs and gave the company a "buy" rating in a research note on Monday, August 4th. Northland Securities cut shares of Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 target price for the company. in a research note on Tuesday, July 22nd. Evercore ISI lifted their target price on shares of Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a research note on Wednesday, August 6th. Finally, Northland Capmk cut Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $142.00.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.